MedPath

Efficacy,of Jatamamsitailam nasya,gudapippalimoola avalehya and Sirodhara with Jatamamsi taila in primary insomnia

Phase 3
Conditions
Health Condition 1: G00-G99- Diseases of the nervous system
Registration Number
CTRI/2023/12/060903
Lead Sponsor
Soma Alekya
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients who present with clinical features of sleeplessness.

Patients who are indicated for Nasya and Sirodhara karma.

Patients willing to give written consent.

Exclusion Criteria

1) Patients of age group below 20 years and above 60 years of either gender.

2) Patients contraindicated for Sirodhara karma and Nasya karma

3) Patient using known medication for anxiety and sedative or any psychiatric medicine

4) Patients suffering with secondary insomnia

5) Associated with major diseases like malignancy, epilepsy, Uncontrolled Hypertension and

Diabetes

6) Pregnant ladies and lactating mothers.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath